Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7295 p465
17 April 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
BBC news and related links (more)
Depression Alliance (www.depressionalliance.org)


Progress is slow for acute mental health care services, despite national guidelines

Little progress has been made on the state of UK hospital care for people with psychiatric illness, despite 650 national strategies, guidelines, frameworks and protocols issued by the Government over the past five years.

This is the conclusion of a report published last week by three national mental health charities — Rethink, SANE and The Zito Trust.

The report considers patients’ experiences when admitted to hospital and finds services lacking. In particular, the charities say that first-line prescribing of newer atypical antipsychotics remains patchy.

The report also highlights some positive changes to the experiences of patients with mental health problems. Formulation developments in atypical antipsychotic drug treatments are a step forward. Mike Isaac, consultant psychiatrist at the South London and Maudsley NHS Trust, commented: “Newly admitted patients requiring rapid tranquillisation can be spared the notorious side effects associated with conventional drugs. The most significant implication of this is that a patient’s first encounter with antipsychotic medication can act as a blueprint for their future attitude towards therapy.”

Copies of the report, “Behind closed doors”, which was supported by Eli Lilly & Company, can be obtained from Rethink (tel 0845 4560455 or e-mail info@rethink.org).

National Depression Week 2004 will run from 19 to 25 April.

Back to Top


©The Pharmaceutical Journal